Form 8-K - Current report:
SEC Accession No. 0001485003-22-000107
Filing Date
2022-08-08
Accepted
2022-08-08 08:00:30
Documents
20
Period of Report
2022-08-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sesn-20220808.htm   iXBRL 8-K 40490
2 EX-99.1 a20220808_2q2022earnings.htm EX-99.1 25266
6 a20220808_2q2022earnings001.jpg GRAPHIC 246732
7 a20220808_2q2022earnings002.jpg GRAPHIC 261154
8 a20220808_2q2022earnings003.jpg GRAPHIC 307055
9 a20220808_2q2022earnings004.jpg GRAPHIC 331669
10 a20220808_2q2022earnings005.jpg GRAPHIC 114527
11 a20220808_2q2022earnings006.jpg GRAPHIC 141537
12 a20220808_2q2022earnings007.jpg GRAPHIC 122502
  Complete submission text file 0001485003-22-000107.txt   2316775

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sesn-20220808.xsd EX-101.SCH 1902
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sesn-20220808_lab.xml EX-101.LAB 24849
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sesn-20220808_pre.xml EX-101.PRE 13046
14 EXTRACTED XBRL INSTANCE DOCUMENT sesn-20220808_htm.xml XML 11810
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

EIN.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 221142599
SIC: 2834 Pharmaceutical Preparations